Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Chinook Therapeutics Inc.

    NASDAQ: KDNY · Real-Time Price · USD
    40.39
    0.09 (0.22%)
    At close: Aug 10, 2023, 10:00 PM

    Chinook Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Revenue
    		 6.13M 51.63M
    Cost of Revenue
    		 1.72M 1.69M
    Gross Profit
    		 4.41M 49.94M
    Operating Income
    		 -185.08M -99.04M
    Interest Income
    		 n/a n/a
    Pretax Income
    		 -180.27M -99.21M
    Net Income
    		 -184.62M -101.3M
    Selling & General & Admin
    		 36.29M 31.9M
    Research & Development
    		 141.21M 96.99M
    Other Expenses
    		 1.72M 1.69M
    Operating Expenses
    		 179.22M 130.57M
    Interest Expense
    		 7.18M n/a
    Selling & Marketing Expenses
    		 n/a n/a
    Cost & Expenses
    		 179.22M 130.57M
    Income Tax Expense
    		 4.34M 2.09M
    Shares Outstanding (Basic)
    		 64.37M 45.61M
    Shares Outstanding (Diluted)
    		 64.37M 45.61M
    EPS (Basic)
    		 -2.87 -2.22
    EPS (Diluted)
    		 -2.87 -2.22
    EBITDA
    		 -164.2M -57.17M
    EBIT
    		 -173.1M -99.04M
    Depreciation & Amortization
    		 20.89M 41.87M

    Add to Watchlist